About Colbar LifeScience
Colbar LifeScience is a company based in Herzliya (Israel) founded in 1995 was acquired by Johnson & Johnson in July 2006.. Colbar LifeScience has raised $28.45 million across 4 funding rounds from investors including Johnson & Johnson, Genesis Partners and SCP Vitalife. Colbar LifeScience operates in a competitive market with competitors including GSK, Avidity Biosciences, Revance Therapeutics, Sutro Biopharma and Antheia, among others.
- Headquarter Herzliya, Israel
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$28.45 M (USD)
in 4 rounds
-
Latest Funding Round
$7.25 M (USD), Series D
Aug 09, 2004
-
Investors
Johnson & Johnson
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Johnson & Johnson
(Jul 06, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Colbar LifeScience
Colbar LifeScience has successfully raised a total of $28.45M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $7.25 million completed in August 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $7.2M
-
First Round
First Round
(01 Jun 1999)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2004 | Amount | Series D - Colbar LifeScience | Valuation |
investors |
|
| Oct, 2003 | Amount | Series C - Colbar LifeScience | Valuation |
investors |
|
| Dec, 2000 | Amount | Series B - Colbar LifeScience | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Colbar LifeScience
Colbar LifeScience has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson, Genesis Partners and SCP Vitalife. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage VC Firm investing in Israel and the US
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on life science investments.
|
Founded Year | Domain | Location | |
|
Venture capital investments in tech and healthtech sectors through dedicated funds.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Colbar LifeScience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Colbar LifeScience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Colbar Lifescience Comparisons
Competitors of Colbar LifeScience
Colbar LifeScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Revance Therapeutics, Sutro Biopharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Colbar Lifescience
Frequently Asked Questions about Colbar LifeScience
When was Colbar LifeScience founded?
Colbar LifeScience was founded in 1995 and raised its 1st funding round 4 years after it was founded.
Where is Colbar LifeScience located?
Colbar LifeScience is headquartered in Herzliya, Israel. It is registered at Herzliya, Central District, Israel.
Is Colbar LifeScience a funded company?
Colbar LifeScience is a funded company, having raised a total of $28.45M across 4 funding rounds to date. The company's 1st funding round was a Series B of $9M, raised on Jun 01, 1999.
What does Colbar LifeScience do?
Colbar LifeScience was established in 1995 in Herzliya, Israel, within the biotechnology sector. Focus was placed on reconstructive therapies using collagen for tissue generation. Two products were developed: Ossix, a resorbable membrane sourced from bovine collagen to support bone regeneration after tooth extractions, and Evolence, an injectable filler employing patented Glymatrix technology with D-Ribose for wrinkle treatment. Operations centered on these regenerative medical applications.
Who are the top competitors of Colbar LifeScience?
Colbar LifeScience's top competitors include Revance Therapeutics, Sutro Biopharma and Synthego.
Who are Colbar LifeScience's investors?
Colbar LifeScience has 5 investors. Key investors include Johnson & Johnson, Genesis Partners, SCP Vitalife, Pitango, and Evergreen Venture Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.